OWEN N. WITTE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for OWEN N. WITTE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of OWEN N. WITTE. OWEN N. WITTE is Director in Kite Pharma, Inc. ($KITE) and in Allogene Therapeutics, Inc. ($ALLO) and Director in Allogene Therapeutics, Inc. ($ALLO).
Latest Insider Trading Transactions of OWEN N. WITTE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Option Exercise | A | 25.76 | 28,015 | 721,666 | 28,015 | ||
Jun 11 2021 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Sell | S | 25.05 | 9,969 | 249,723 | 236,182 | 246.2 K to 236.2 K (-4.05 %) | |
Jun 09 2020 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Grant | A | 0.00 | 9,969 | 0 | 246,151 | 236.2 K to 246.2 K (+4.22 %) | |
Jun 24 2019 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Director | Option Exercise | A | 25.95 | 26,025 | 675,349 | 26,025 | |
Oct 17 2018 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Director | Option Exercise | C | 0.00 | 7,130 | 0 | 0 | |
Oct 17 2018 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Director | Buy | C | 0.00 | 37,432 | 0 | 236,182 | 198.8 K to 236.2 K (+18.83 %) |
Oct 17 2018 | ALLO | Allogene Therapeut ... | WITTE OWEN N. | Director | Buy | P | 18.00 | 15,000 | 270,000 | 198,750 | 183.8 K to 198.8 K (+8.16 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | D | 83.89 | 17,130 | 1,437,036 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | D | 55.09 | 30,000 | 1,652,700 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | D | 6.89 | 10,000 | 68,900 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | D | 0.00 | 5,715 | 0 | 0 | 5.7 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | U | 180.00 | 58,535 | 10,536,300 | 5,715 | 64.3 K to 5.7 K (-91.11 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Gift | G | 0.00 | 12,000 | 0 | 64,250 | 76.3 K to 64.3 K (-15.74 %) |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | M | 62.44 | 2,500 | 156,100 | 0 | |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | M | 6.89 | 10,000 | 68,900 | 10,000 | |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | S | 100.60 | 12,500 | 1,257,500 | 76,250 | 88.8 K to 76.3 K (-14.08 %) |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Sell | S | 100.00 | 12,500 | 1,250,000 | 88,750 | 101.3 K to 88.8 K (-12.35 %) |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Buy | M | 62.44 | 2,500 | 156,100 | 101,250 | 98.8 K to 101.3 K (+2.53 %) |
Jun 26 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Buy | M | 6.89 | 10,000 | 68,900 | 98,750 | 88.8 K to 98.8 K (+11.27 %) |
Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Grant | A | 0.00 | 2,410 | 0 | 88,750 | 86.3 K to 88.8 K (+2.79 %) |
Mar 16 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Option Exercise | A | 83.89 | 17,130 | 1,437,036 | 17,130 | |
Mar 16 2017 | KITE | Kite Pharma, Inc. | WITTE OWEN N. | Director | Grant | A | 0.00 | 4,690 | 0 | 86,340 | 81.7 K to 86.3 K (+5.74 %) |
Page: 1